Evidence based thinking for clinical trials of anti-tumor angiogenic agents[J]. Journal of Evidence-Based Medicine, 2002, 2(2): 65-66. DOI: 10.3969/j.issn.1671-5144.2002.02.001
|
Citation:
|
Evidence based thinking for clinical trials of anti-tumor angiogenic agents[J]. Journal of Evidence-Based Medicine, 2002, 2(2): 65-66. DOI: 10.3969/j.issn.1671-5144.2002.02.001
|
Evidence based thinking for clinical trials of anti-tumor angiogenic agents[J]. Journal of Evidence-Based Medicine, 2002, 2(2): 65-66. DOI: 10.3969/j.issn.1671-5144.2002.02.001
|
Citation:
|
Evidence based thinking for clinical trials of anti-tumor angiogenic agents[J]. Journal of Evidence-Based Medicine, 2002, 2(2): 65-66. DOI: 10.3969/j.issn.1671-5144.2002.02.001
|
DownLoad: